Factors Associated with Disclosure of HIV Status Among a Cohort of Individuals on Antiretroviral Therapy in British Columbia, Canada

• Published in: AIDS and behavior Vol. 18; no. 6; pp. 1014 - 1026
• Main Authors: Hirsch Allen, A. J., Forrest, Jamie I., Kanters, Steve, O’Brien, Nadia, Salters, Kate A., McCandless, Lawrence, Montaner, Julio S. G., Hogg, Robert S.
• Format: Journal Article
• Language: English
• Published: Boston Springer US 01.06.2014; Springer Nature B.V
• Subjects: Acquired Immune Deficiency Syndrome; Adolescent; Adult; Anti-HIV Agents - therapeutic use; Antiretroviral agents; Antiretroviral drugs; Bisexuality; British Columbia; British Columbia - epidemiology; Condoms; Disclosure; Disease transmission; Drug therapy; Female; Health behavior; Health Psychology; HIV; HIV Seropositivity - psychology; HIV Seropositivity - transmission; Homosexuality; Human immunodeficiency virus; Humans; Infectious Diseases; Intention; Male; Medications; Medicine; Medicine & Public Health; Middle Aged; Odds Ratio; Original Paper; Public Health; Self Disclosure; Self Report; Sexual Behavior; Sexual Behavior - psychology; Sexual Partners - psychology; Sexually transmitted diseases; STD; Surveys and Questionnaires; Truth Disclosure; Vulnerability; British Columbia; HIV/AIDS; Women; Gay/bisexual men; Disclosure; HIV transmission
• ISSN: 1090-7165; 1573-3254
• DOI: 10.1007/s10461-013-0623-9

We sought to examine the prevalence and correlates of HIV-disclosure among treatment-experienced individuals in British Columbia, Canada. Study participants completed an interviewer-administered survey between July 2007 and January 2010. The primary outcome of interest was disclosing one’s HIV-positive status to all new sexual partners within the last 6 months. An exploratory logistic regression model was developed to identify variables independently associated with disclosure. Of the 657 participants included in this analysis, 73.4 % disclosed their HIV-positive status to all of their sexual partners. Factors independently associated with non-disclosure included identifying as a woman (adjusted odds ratio [AOR] 1.92; 95 % confidence interval [95 % CI] 1.13–3.27) or as a gay or bisexual man (AOR 2.45; 95 % CI 1.47–4.10). Behaviours that were independently associated with non-disclosure were having sex with a stranger (AOR 2.74; 95 % CI 1.46–5.17), not being on treatment at the time of interview (AOR 2.67; 95 % CI 1.40–5.11), and not always using a condom (AOR 1.78; 95 % CI 1.09–2.90). Future preventative strategies should focus on environmental and social factors that may inhibit vulnerable HIV-positive populations, such as women and gay or bisexual men, from safely disclosing their positive status.